Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Hox, V; Lourijsen, E; Jordens, A; Aasbjerg, K; Agache, I; Alobid, I; Bachert, C; Boussery, K; Campo, P; Fokkens, W; Hellings, P; Hopkins, C; Klimek, L; Mäkelä, M; Mösges, R; Mullol, J; Pujols, L; Rondon, C; Rudenko, M; Toppila-Salmi, S; Scadding, G; Scheire, S; Tomazic, PV; Van Zele, T; Wagemann, M; van Boven, JFM; Gevaert, P.
Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper.
Clin Transl Allergy. 2020; 10: 1-1.
Doi: 10.1186/s13601-019-0303-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Tomazic Peter Valentin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Because of the inflammatory mechanisms of most chronic upper airway diseases such as rhinitis and chronic rhinosinusitis, systemic steroids have been used for their treatment for decades. However, it has been very well documented that-potentially severe-side-effects can occur with the accumulation of systemic steroid courses over the years. A consensus document summarizing the benefits of systemic steroids for each upper airway disease type, as well as highlighting the potential harms of this treatment is currently lacking. Therefore, a panel of international experts in the field of Rhinology reviewed the available literature with the aim of providing recommendations for the use of systemic steroids in treating upper airway disease. © The Author(s) 2020.
- Find related publications in this database (Keywords)
- Glucocorticosteroids
- Rhinitis
- Rhinosinusitis